1. Agah R, Malloy B, Sherrod A, Bean P, Girgis E, Mazumder A (1988) Therapy of disseminated NK-resistant tumour by the synergistic effects of recombinant interleukin-2 and tumour necrosis factor. J Biol Response Mod 7: 140–151
2. Belardelli F, Ciolli V, Testa U, Montesoro E, Bulgarini D, Proietti E, Borghi P, Sestili P, Locardi C, Peschle C, Gresser I (1989) Antitumour effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumors. Int J Cancer 44: 1108–1116
3. Berger MR, Habs M, Schmähl D (1983) Noncarcinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in rats. Int J Cancer 32: 231–236
4. Berger MR, Bischoff H, Fritschi E, Henne T, Herrmann M, Pool B, Satzinger G, Schmähl D, Weiershausen U (1985) Synthesis, toxicity, and therapeutic efficacy of 4-amino-N-(2′-aminophenyl)-benzamide: a new compound preferentially active in slowly growing tumors. Cancer Treat Rep 69: 1415–1424
5. Berger MR, Bischoff H, Garzon FT, Schmähl D (1986) Autochthonous, acetoxymethyl-methylnitrosamine-induced colorectal cancer in rats: a useful tool in selecting new active antineoplastic compounds? Hepatogastroenterology 33: 227–234